1921
Volume 82, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Duffy binding protein (DBP), a leading malaria vaccine candidate, plays a critical role in erythrocyte invasion. Sixty-eight of 366 (18.6%) subjects had IgG anti-DBP antibodies by enzyme-linked immunosorbent assay (ELISA) in a community-based cross-sectional survey in the Brazilian Amazon Basin. Despite continuous exposure to low-level malaria transmission, the overall seroprevalence decreased to 9.0% when the population was reexamined 12 months later. Antibodies from 16 of 50 (36.0%) subjects who were ELISA-positive at the baseline were able to inhibit erythrocyte binding to at least one of two DBP variants tested. Most (13 of 16) of these subjects still had inhibitory antibodies when reevaluated 12 months later. Cumulative exposure to malaria was the strongest predictor of DBP seropositivity identified by multiple logistic regression models in this population. The poor antibody recognition of DBP elicited by natural exposure to in Amazonian populations represents a challenge to be addressed by vaccine development strategies.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.08-0580
2010-02-01
2017-09-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/82/2/185.html?itemId=/content/journals/10.4269/ajtmh.2010.08-0580&mimeType=html&fmt=ahah

References

  1. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW, , 2004. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 4: 327336.[Crossref]
  2. Guerra CA, Snow RW, Hay SI, , 2006. Defining the global spatial limits of malaria transmission in 2005. Adv Parasitol 62: 157179.[Crossref]
  3. Baird JK, , 2007. Neglect of Plasmodium vivax malaria. Trends Parasitol 23: 533539.[Crossref]
  4. Genton B, D’Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I, , 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: 881889.[Crossref]
  5. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN, , 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: 890899.[Crossref]
  6. McHenry AM, Adams JH, , 2006. The crystal structure of P. knowlesi DBP alpha DBL domain and its implications for immune evasion. Trends Biochem Sci 31: 487491.[Crossref]
  7. Chitnis CE, Sharma A, , 2008. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol 24: 2934.[Crossref]
  8. Miller L, Mason S, Clyde D, McGinniss M, , 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302304.[Crossref]
  9. Wertheimer SP, Barnwell JW, , 1989. Plasmodium vivax interaction with the human Duffy blood-group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol 69: 340350.[Crossref]
  10. Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, Sattabongkot J, Cui L, Bockarie M, Chitnis C, Adams J, Zimmerman PA, King CL, , 2007. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 4: 19401948.[Crossref]
  11. Ranjan A, Chitnis CE, , 1999. Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. Proc Natl Acad Sci USA 96: 1406714072.[Crossref]
  12. Singh SK, Singh AP, Pandey S, Yazdani SS, Chitnis CE, Sharma A, , 2003. Definition of structural elements in Plasmodium vivax and P. knowlesi Duffy-binding domains necessary for erythrocyte invasion. Biochem J 374: 193198.[Crossref]
  13. VanBuskirk KM, Sevova E, Adams JH, , 2004. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc Natl Acad Sci USA 101: 1575415759.[Crossref]
  14. Michon P, Fraser T, Adams JH, , 2000. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect Immun 68: 31643171.[Crossref]
  15. Ceravolo IP, Souza-Silva FA, Fontes CJF, Braga EM, Madureira AP, Krettli AU, Souza JM, Brito CFA, Adams JH, Carvalho LH, , 2008. Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission. Scand J Immunol 67: 270278.[Crossref]
  16. King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, Zimmerman PA, Cole-Tobian JL, Mueller I, Chitnis CE, , 2008. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci USA 105: 83638368.[Crossref]
  17. Fraser T, Michon P, Barnwell JW, Noe AR, AlYaman F, Kaslow DC, Adams JH, , 1997. Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. Infect Immun 65: 27722777.
  18. Xainli J, Cole-Tobian JL, Baisor M, Kastens W, Bockarie M, Yazdani SS, Chitnis CE, Adams JH, King CL, , 2003. Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. Infect Immun 71: 25082515.[Crossref]
  19. Ceravolo IP, Bruna-Romero O, Braga EM, Fontes CJF, Brito CFA, Souza JM, Krettli AU, Adams JH, Carvalho LH, , 2005. Anti-Plasmodium vivax Duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. Am J Trop Med Hyg 72: 675681.
  20. da Silva-Nunes M, Codeço CT, Malafronte RS, Silva NS, Juncansen C, Muniz PT, Ferreira MU, , 2008. Malaria on the Amazonian frontier: transmission dynamics, risk factors, spatial distribution, and prospects for control. Am J Trop Med Hyg 79: 624635.
  21. Cavasini M, Ribeiro W, Kawamoto F, Ferreira M, , 2000. How prevalent is Plasmodium malariae in Rondônia, western Brazilian Amazon? Rev Soc Bras Med Trop 33: 489492.[Crossref]
  22. Scopel K, Fontes C, Nunes A, Horta M, Braga E, , 2004. Low sensitivity of nested PCR using Plasmodium DNA extracted from stained thick blood smears: an epidemiological retrospective study among subjects with low parasitaemia in an endemic area of the Brazilian Amazon region. Malar J 3: 8.[Crossref]
  23. Kimura M, Kaneko O, Qing L, Mian Z, Kawamoto F, Wataya Y, Otani S, Yamaguchi Y, Tanabe K, , 1997. Identification of the four species of human malaria parasites by nested PCR that targets variant sequences in the small subunit rRNA gene. Parasitol Int 46: 91154.[Crossref]
  24. Win T, Lin K, Mizuno S, Zhou M, Liu Q, Ferreira M, Tantular I, Kojima S, Ishii A, Kawamoto F, , 2002. Wide distribution of Plasmodium ovale in Myanmar. Trop Med Int Health 7: 231239.[Crossref]
  25. Karunaweera N, Carter R, Grau G, Mendis K, , 1998. Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease. Am J Trop Med Hyg 58: 204210.
  26. Silva-Nunes M, Malafronte RS, Luz BA, Souza E, Martins L, Rodrigues S, Chiang J, Vasconcelos P, Muniz P, Ferreira M, , 2006. The Acre Project: the epidemiology of malaria and arthropod-borne virus infections in a rural Amazonian population. Cad Saude Publica 22: 13251334.[Crossref]
  27. Fang XD, Kaslow DC, Adams JH, Miller LH, , 1991. Cloning of the Plasmodium-vivax Duffy receptor. Mol Biochem Parasitol 44: 125132.[Crossref]
  28. Chitnis C, Miller L, , 1994. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 180: 497506.[Crossref]
  29. Sousa T, Cerávolo I, Fernandes Fontes C, Couto A, Carvalho L, Brito C, , 2006. The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area. Mol Biochem Parasitol 146: 251254.[Crossref]
  30. Bastos MS, da Silva-Nunes M, Malafronte RS, Hoffmann EHE, Wunderlich G, Moraes SL, Ferreira MU, , 2007. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians. Clin Vaccine Immunol 14: 12491259.[Crossref]
  31. Adams JH, Hudson DE, Torii M, Ward GE, Wellems TE, Aikawa M, Miller LH, , 1990. The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63: 141153.[Crossref]
  32. Cowman A, Crabb B, , 2006. Invasion of red blood cells by malaria parasites. Cell 124: 755766.[Crossref]
  33. Carvalho LH, Fontes CJE, Krettli AU, , 1999. Cellular responses to Plasmodium falciparum major surface antigens and their relationship to human activities associated with malaria transmission. Am J Trop Med Hyg 60: 674679.
  34. Barbieri AF, Sawyer DO, , 2007. Heterogeneity of malaria prevalence in alluvial gold mining areas in northern Mato Grosso State, Brazil. Cad Saude Publica 23: 28782886.[Crossref]
  35. Santos E, Loureiro E, Jesus I, Brabo E, Silva R, Soares M, Câmara V, Souza M, Branches F, , 1995. Diagnosis of health conditions in a pan-mining community in the Tapajós River Basin, Itaituba, Par, Brazil, 1992. Cad Saude Publica 11: 212225.[Crossref]
  36. Silbergeld E, Nash D, Trevant C, Strickland G, de Souza J, da Silva R, , 2002. Mercury exposure and malaria prevalence among gold miners in Pará, Brazil. Rev Soc Bras Med Trop 35: 421429.[Crossref]
  37. Singh SK, Hora R, Belrhali H, Chitnis CE, Sharma A, , 2006. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439: 741744.[Crossref]
  38. Cole-Tobian JL, Michon P, Dabod E, Mueller I, King CL, , 2007. Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein polymorphisms in relation to parasitemia levels in Papua New Guinean children. Am J Trop Med Hyg 77: 955962.
  39. Richie T, , 2006. High road, low road? Choices and challenges on the pathway to a malaria vaccine. Parasitology 133: S113S144.[Crossref]
  40. Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, Tetteh KKA, Polley S, Conway DJ, Holder AA, Bacarese-Hamilton T, Riley EM, Crisanti A, , 2007. Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin Chem 53: 12441253.[Crossref]
  41. Langhorne J, Ndungu FM, Sponaas AM, Marsh K, , 2008. Immunity to malaria: more questions than answers. Nat Immunol 9: 725732.[Crossref]
  42. Camargo L, Ferreira M, Krieger H, De Camargo E, Da Silva L, , 1994. Unstable hypoendemic malaria in Rondonia (western Amazon region, Brazil): epidemic outbreaks and work-associated incidence in an agro-industrial rural settlement. Am J Trop Med Hyg 51: 1625.
  43. VanBuskirk KM, Cole-Tobian JL, Baisor M, Sevova ES, Bockarie M, King CL, Adams JH, , 2004. Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. J Infect Dis 190: 15561562.[Crossref]
  44. Ceravolo I, Sanchez B, Sousa T, Guerra B, Soares I, Braga E, McHenry A, Adams J, Brito C, Carvalho L, , 2009. Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin Exp Immunol 156: 502510.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.08-0580
Loading
/content/journals/10.4269/ajtmh.2010.08-0580
Loading

Data & Media loading...

Supplementary Data

Supplementary figure 1

Supplementary figure 2

  • Received : 06 Nov 2008
  • Accepted : 15 Sep 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error